DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

Saturday 4 February 2017

Kate Ashton

Kate Ashton
Kate Ashton
Senior Scientist at Amgen, Inc
Amgen
Thousand Oaks, United States
Dr. Kate Ashton received a Masters in Chemistry with Industrial Experience from the University of Edinburgh. She conducted her PhD thesis research on the synthesis and structure elucidation of Reidispongiolide A with Prof. Ian Paterson at the University of Cambridge, and her postdoctoral work on SOMO catalysis with Prof. David W. C. MacMillan at both Caltech and Princeton. 

She has been at Amgen for 6 years and has worked on indications for cancer, Alzheimer’s and diabetes.Dr Fecke works in the area of industrial early drug discovery since 1996. He is currently Group Leader in the Primary Pharmacology department at UCB Pharma (UK) and is involved in the identification and characterization of NCE and NBE drugs in molecular interaction assays for both immunological and CNS diseases. 

Prior to joining UCB, he worked for Novartis and Siena Biotech in the areas of transplant rejection, neurodegeneration and oncology. He obtained his PhD at the Heinrich-Heine-University Dusseldorf in Germany in 1994.



Image result for amg 3969

AMG-3969

M.Wt: 522.46
Cas : 1361224-53-4 , MF: C21H20F6N4O3S
WO 2012027261 PRODUCT PATENT
                   Kate AshtonMichael David BartbergerYunxin BoMarian C. BryanMichael CroghanChristopher Harold FotschClarence Henderson HaleRoxanne Kay KunzLongbin LiuNobuko NishimuraMark H. NormanLewis Dale PenningtonSteve Fong PoonMarkian Myroslaw StecJean David Joseph St., Jr.Nuria A. TamayoChristopher Michael TegleyKevin Chao Yang

Amgen Inc.
2-[4-[(2S)-4-[(6-Amino-3-pyridinyl)sulfonyl]-2-(1-propyn-1-yl)-1-piperazinyl]phenyl]-1,1,1,3,3,3-hexafluoro-2-propanol)


MAKING CONNECTIONS Aleksandra Baranczak (right), a fourth-year grad student in Gary A. Sulikowski’s lab at Vanderbilt University, discusses her efforts to synthesize the core of the diazo-containing natural product lomaiviticin A with Kate Ashton, a medicinal chemist at Amgen

Experience

Senior Scientist

Amgen, Inc.
 – Present (9 years 5 months)

Postdoctoral Fellow

Princeton University
 –  (7 months)

Postdoctoral Fellow

California Institute of Technology
 –  (1 year 7 months)

Research Associate

Merck, UK
 –  (1 year 4 months)

Education

University of Cambridge

Doctor of Philosophy (PhD), Organic Chemistry

Edinburgh University

Masters with Industrial Experience, Organic Chemistry
///////////